+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Dicerna Pharmaceuticals Inc (DRNA) - Financial and Strategic SWOT Analysis Review

  • ID: 4284663
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2

Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies.The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined. Its pipeline product is being generated from the company’s proprietary RNA interference. Dicerna’s pipeline products comprise DCR-PH1, KRAS Program, primary hyperoxaluria 1 and hepatocellular carcinoma. The company provides RNAi-targeted drugs, delivery systems and DsiRNA molecules. It also offers traditional therapeutic modalities, such as small molecules and monoclonal antibodies. The company offers its drug discovery and development activities that are based on the therapeutic modality of RNAi. It develops therapoes for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. Dicerna is headquartered in Cambridge, Massachusetts, the US.

Dicerna Pharmaceuticals Inc Key Recent Developments

Nov 02, 2017: Dicerna Reports Third Quarter 2017 Financial and Operating Results and Provides Corporate Update
Aug 10, 2017: Dicerna Reports Second Quarter 2017 Financial and Operating Results and Provides Corporate Update
Jun 15, 2017: Dicerna Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun 08, 2017: Dicerna Announces Appointment of Ralf Rosskamp, M.D., as Chief Medical Officer
May 08, 2017: Dicerna Reports First Quarter 2017 Financial and Operational Results and Provides Corporate Update

This comprehensive SWOT profile of Dicerna Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Dicerna Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 2
Section 1 - About the Company
  • Dicerna Pharmaceuticals Inc - Key Information
  • Dicerna Pharmaceuticals Inc - Overview
  • Dicerna Pharmaceuticals Inc - Key Employees
  • Dicerna Pharmaceuticals Inc - Key Employee Biographies
  • Dicerna Pharmaceuticals Inc - Key Operational Heads
  • Dicerna Pharmaceuticals Inc - Major Products and Services
  • Dicerna Pharmaceuticals Inc - History
  • Dicerna Pharmaceuticals Inc - Company Statement
  • Dicerna Pharmaceuticals Inc - Locations And Subsidiaries
  • Dicerna Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Dicerna Pharmaceuticals Inc - Business Description
  • Dicerna Pharmaceuticals Inc - Corporate Strategy
  • Dicerna Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Dicerna Pharmaceuticals Inc - Strengths
  • Dicerna Pharmaceuticals Inc - Weaknesses
  • Dicerna Pharmaceuticals Inc - Opportunities
  • Dicerna Pharmaceuticals Inc - Threats
  • Dicerna Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Dicerna Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Dicerna Pharmaceuticals Inc, Key Information
  • Dicerna Pharmaceuticals Inc, Key Ratios
  • Dicerna Pharmaceuticals Inc, Share Data
  • Dicerna Pharmaceuticals Inc, Major Products and Services
  • Dicerna Pharmaceuticals Inc, History
  • Dicerna Pharmaceuticals Inc, Key Employees
  • Dicerna Pharmaceuticals Inc, Key Employee Biographies
  • Dicerna Pharmaceuticals Inc, Key Operational Heads
  • Dicerna Pharmaceuticals Inc, Other Locations
  • Dicerna Pharmaceuticals Inc, Subsidiaries
  • Dicerna Pharmaceuticals Inc, Key Manufacturing facilities
  • Dicerna Pharmaceuticals Inc, Key Competitors
  • Dicerna Pharmaceuticals Inc, SWOT Analysis
  • Dicerna Pharmaceuticals Inc, Ratios based on current share price
  • Dicerna Pharmaceuticals Inc, Annual Ratios
  • Dicerna Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Dicerna Pharmaceuticals Inc, Performance Chart
  • Dicerna Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown